These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33501850)

  • 1. Evaluation of the relation between cardiac biomarkers and thorax computed tomography findings in COVID-19 patients.
    Ileri C; Dogan Z; Ozben B; Karaoglu C; Gunay N; Tigen K; Basat S; Uyan C
    Biomark Med; 2021 Mar; 15(4):285-293. PubMed ID: 33501850
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT.
    Ferreira RM; de Oliveira GS; da Rocha JR; Mc Ribeiro F; Stern JJ; S Costa R; Lemgruber RN; Ramalho JF; de Almeida AC; Sampaio PP; Filho JM; Lima RA
    Biomark Med; 2022 Mar; 16(4):291-301. PubMed ID: 35176874
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between laboratory parameters and CT severity in patients infected with Covid-19: A retrospective, observational study.
    Yilmaz A; Sabirli R; Seyit M; Ozen M; Oskay A; Cakmak V; Goren T; Turkcuer I
    Am J Emerg Med; 2021 Apr; 42():110-114. PubMed ID: 33503532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).
    Xie Y; You Q; Wu C; Cao S; Qu G; Yan X; Han X; Wang C; Zhang H
    Circ J; 2020 Jul; 84(8):1277-1283. PubMed ID: 32536672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a lower cutoff of high sensitivity troponin I in identification of early cardiac damage in non-severe patients with COVID-19.
    Lin Y; Yan K; Chen L; Wu Y; Liu J; Chen Y; Hou B; Zhong P
    Sci Rep; 2022 Feb; 12(1):2389. PubMed ID: 35149778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19.
    Chen L; Hu W; Guo X; Zhao P; Tang J; Gu Y; Huang N; Wang C; Cui A; Zhang D; Hu L; Feng Y; Hu S; Chen M; Duru F; Xiong C
    Sci Rep; 2021 Feb; 11(1):4432. PubMed ID: 33627696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between biomarkers of lung injury and 1-year mortality in COVID-19.
    Atalay B; Cesur A; Agirbasli M
    Eur J Clin Invest; 2022 Sep; 52(9):e13827. PubMed ID: 35753029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
    Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
    Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual classification of three computed tomography lung patterns to predict prognosis of COVID-19: a retrospective study.
    Yamada D; Ohde S; Imai R; Ikejima K; Matsusako M; Kurihara Y
    BMC Pulm Med; 2022 Jan; 22(1):1. PubMed ID: 34980061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
    Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
    Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring.
    Zaninotto M; Mion MM; Padoan A; Babuin L; Plebani M
    Clin Chim Acta; 2020 Dec; 511():75-80. PubMed ID: 33010244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
    Santotoribio JD; Nuñez-Jurado D; Lepe-Balsalobre E
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between chest-CT and laboratory parameters in SARS-CoV-2 pneumonia: A single-center study from Italy.
    Orlacchio A; Gasparrini F; Roma S; Ravà MS; Salvatori E; Morosetti D; Cossu E; Legramante JM; Paganelli C; Bernardini S; Minieri M
    Medicine (Baltimore); 2021 Apr; 100(14):e25310. PubMed ID: 33832103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
    Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Vafai-Tabrizi F; Gschwantler M; Fasching P; Wojta J; Giannitsis E; Huber K
    Clin Res Cardiol; 2022 Mar; 111(3):343-354. PubMed ID: 34782921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.